I was moved by this editorial on global health matters in a daily British newspaper by an academic medical colleague, written in response to anticipated changes in the leadership of the World Health Organisation. It is perhaps time for us surgeons to augment our administrative participation in global healthcare.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
May 8, 2017
Researchers conducted a study, published in Nature, to investigate whether this genetic diversity could be tracked clinically.
May 3, 2017
This video shows a redo right upper lobe microlobectomy for a second primary tumor.
April 23, 2017
Check out this focused issue by JOVS with partecipation of major experts from the globe. Is subxiphoid approach the future for lung resections?
April 19, 2017
This video shows a robotic lingulectomy and lymphadenectomy in a 62-year-old non-smoker with a history of Dukes' B colorectal adenocarcinoma.
April 17, 2017
In a retrospective review of patients undergoing esophagectomy at two high volume centers, the incidence of hiatal hernia was 5% - 10%. The incidence did not differ between open and MIE approaches. Two-thirds of the hernias were discovered incidentally, although half of those patients were symptomatic.
March 31, 2017
This video demonstrates sharp dissection of vascular structures during VATS lobectomy.
March 27, 2017
Evidence for the benefit of sleeve lobectomy over pneumonectomy for lung cancer is limited. This 10 year retrospective nationwide study compared propensity score matched sleeve resection and pneumonectomy patients (794 in each group). Postoperative outcomes and long-term disease-free survival were superior in the sleeve resection patients when matc
March 24, 2017
Paul Van Schil of Antwerp University Hospital, Antwerp, Belgium argues that surgery offers the best outcome for patients with mesothelioma.
March 16, 2017
Robert Rintoul of Papworth Hospital, Cambridge, UK, reviews the outcomes of major mesothelioma trials, and argues that all mesothelioma surgery is currently palliative.